Regulus Therapeutics logo

Regulus Therapeutics

Regulus Therapeutics Inc. (Nasdaq:RGLS) is a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs. Regulus has leveraged its oligonucleotide drug discovery and development expertise to develop a well-balanced microRNA therapeutics pipeline complemented by a maturing microMarkersSM biomarkers platform and a rich intellectual property estate to retain its leadership in the microRNA field. Regulus is located in San Diego, California and is led by a seasoned executive team experienced in corporate management, business, science, drug discovery and development. Regulus' scientific advisory board consists of world-class scientists and some of the foremost authorities in the field of microRNA research.

Free account • No credit card • 5 profiles/day

Biotechnology Research 39 Employees Found San Diego, United States Founded 2007 10 Similar Companies
39 Employees Found
93% Email Coverage
$531.0K Est Revenue
1 Office HQ
10 Similar Companies
Jun '26 Last Verified

Frequently asked questions about Regulus Therapeutics

What is Regulus Therapeutics email format?

The widely used Regulus Therapeutics email format is {first_initial}{last} (e.g. jsmith@regulusrx.com) with 80% adoption across the company.

What is Regulus Therapeutics customer service number?

To contact Regulus Therapeutics customer service number in your country click here to find.

Who are the decision makers in Regulus Therapeutics?

The decision makers in Regulus Therapeutics are Preston Klassen, Rekha Garg, Cris Calsada, etc. Click to Find Regulus Therapeutics decision makers emails.